Skip to content

Eton Pharmaceuticals, Inc.

ETON

CIK 0001710340

← back to feed
Revenue (TTM)
$82.94M
+104.9% YoY Q1 May 2026
Net Income (TTM)
−$4.53M
−20.4% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.06
Q1 May 2026
Gross Margin
53.5%
Q1 May 2026
Operating Margin
-1.1%
Q1 May 2026
Net Margin
-5.5%
Q1 May 2026
Free Cash Flow (TTM)
$5.39M
Q1 May 2026
Cash
$19.66M
Q1 May 2026
Total Debt
$30.75M
Q1 May 2026
Shares Outstanding
27.39M sh
Q1 May 2026

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings